Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Dobson

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 29, 2020
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS RegisterNikos Evangelou, Afagh Garjani, Roshan dasNair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Therapeutic Advances in Neurological Disorders|July 14, 2020
Sex effects across the lifespan in women with multiple sclerosisKristen M Krysko, Jennifer S Graves, Ruth Dobson, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
Multiple Sclerosis and Related Disorders|March 29, 2024
A study of referral bias in NMOSD and MOGAD cohortsMiguel Leal Rato, Bo Chen, Anna Francis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 29, 2020
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS RegisterNikos Evangelou, Afagh Garjani, Roshan dasNair, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 11, 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's diseaseRuth Dobson, Katherine Patterson, Reshad Malik, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Therapeutic Advances in Neurological Disorders|July 14, 2020
Sex effects across the lifespan in women with multiple sclerosisKristen M Krysko, Jennifer S Graves, Ruth Dobson, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 19